Newer anti-hyperglycemic agents in type 2 diabetes mellitus – Expanding the horizon
Tài liệu tham khảo
Uwaifo, 2005, Novel pharmacologic agents for type 2 diabetes, Endocrinol Metab Clin N Am, 34, 155, 10.1016/j.ecl.2004.11.006
Kalra, 2013, Recent advances in pathophysiology of diabetes: beyond the dirty dozen, J Pakistan Med Assoc, 63, 277
Nagasumi, 2009, Overexpression of GPR40 in pancreatic β-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice, Diabetes, 58, 1067, 10.2337/db08-1233
Kaku, 2013, Randomized double- blind, dose ranging study of TAK-875, a novel GPR40 agonist in Japanese patients with inadequately controlled type 2 diabetes, Diabetes Care, 36, 245, 10.2337/dc12-0872
Cheon, 2013, Latest research and development trends in non-insulin anti-diabetics, Arch Pharm Res, 36, 145, 10.1007/s12272-013-0016-7
Xiaoyun Zhu, Wenglong Huang and Hai Qian. GPR119 agonists: a novel strategy for type 2 diabetes treatment. Diabetes mellitus – insights and perspectives. Chapter 4.
Edward C, Chao, Henry Robert R. SGLT2 inhibition – a novel strategy for diabetes treatment. Nat Rev Drug Discov AOP, published online 28 May 2010.
Matschinsky, 2013, GKA's for diabetes therapy: why no clinically useful drug after two decades of trying?, Trends Pharmacol Sci, 34, 90, 10.1016/j.tips.2012.11.007
Ge, 2010, 11β hydroxysteroid dehydrogenase type 1 inhibitors as promising therapeutic drugs for diabetes: status and development, Curr Med Chem, 17, 412, 10.2174/092986710790226147
Popoy, 2011, Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control, Biochem Biophys Res Commun, 410, 377, 10.1016/j.bbrc.2011.06.009
Denison, 2013, Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study, Diabetes Obes Metab, 15, 136, 10.1111/dom.12002
Baker, 2005, Glycogen phosphorylase inhibition in type 2 diabetes therapy, Diabetes, 54, 2453, 10.2337/diabetes.54.8.2453
